Comparative Efficacy of Naltrexone Implants, Oral Naltrexone, And Standard Care for Relapse Prevention in Adults with Opioid Use Disorder
Journal of Addiction & Addictive Disorders · 09.10.2026 · 13 (2) · 1-14
DOI: 10.24966/aad-7276/100232 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Addiction & Addictive Disorders, online erschienen am 09.10.2026. Verfasst von Khair Ali TF.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Background: Poor adherence to daily oral naltrexone limits its effectiveness for opioid dependence. Sustained-release naltrexone implants provide continuous opioid receptor blockade for 3-6 months and may improve relapse prevention, retention, and mortality outcomes.
Zitieren
APA
TF, K. A. (2026). Comparative Efficacy of Naltrexone Implants, Oral Naltrexone, And Standard Care for Relapse Prevention in Adults with Opioid Use Disorder. Journal of Addiction & Addictive Disorders, 13(2), 1-14. https://doi.org/10.24966/aad-7276/100232
Vancouver
TF KA. Comparative Efficacy of Naltrexone Implants, Oral Naltrexone, And Standard Care for Relapse Prevention in Adults with Opioid Use Disorder. Journal of Addiction & Addictive Disorders. 2026;13(2):1-14. doi:10.24966/aad-7276/100232
BibTeX
@article{TF2026,
author = {TF, Khair Ali},
title = {Comparative Efficacy of Naltrexone Implants, Oral Naltrexone, And Standard Care for Relapse Prevention in Adults with Opioid Use Disorder},
journal = {Journal of Addiction & Addictive Disorders},
year = {2026},
volume = {13},
number = {2},
pages = {1--14},
doi = {10.24966/aad-7276/100232}
}
EUVIMED